430 related articles for article (PubMed ID: 33227428)
1. Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort Study.
Tapaskar N; Ham SA; Micic D; Sengupta N
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):381-389.e9. PubMed ID: 33227428
[TBL] [Abstract][Full Text] [Related]
2. Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with prior gastrointestinal bleeding: a network meta-analysis of real-world data.
Hu W; Cai H; Zhang J
Eur J Clin Pharmacol; 2022 Jul; 78(7):1057-1067. PubMed ID: 35296907
[TBL] [Abstract][Full Text] [Related]
3. Rebleeding vs Thromboembolism After Hospitalization for Gastrointestinal Bleeding in Patients on Direct Oral Anticoagulants.
Sengupta N; Marshall AL; Jones BA; Ham S; Tapper EB
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1893-1900.e2. PubMed ID: 29775794
[TBL] [Abstract][Full Text] [Related]
4. Outcomes Associated With Resuming Direct Oral Anticoagulant Therapy Following Admission for a Gastrointestinal Bleed.
Valanejad SM; Davis KA; Nisly SA
Ann Pharmacother; 2020 Oct; 54(10):975-980. PubMed ID: 32141301
[TBL] [Abstract][Full Text] [Related]
5. Warfarin Is Associated With Higher Rates of Upper But Not Lower Gastrointestinal Bleeding Compared with Direct Oral Anticoagulants: A Population-Based Propensity-Weighted Cohort Study.
Ingason AB; Hreinsson JP; Agustsson AS; Lund SH; Rumba E; Palsson DA; Reynisson IE; Gudmundsdottir BR; Onundarson PT; Bjornsson ES
Clin Gastroenterol Hepatol; 2023 Feb; 21(2):347-357.e10. PubMed ID: 35977616
[TBL] [Abstract][Full Text] [Related]
6. The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study.
Sengupta N; Feuerstein JD; Patwardhan VR; Tapper EB; Ketwaroo GA; Thaker AM; Leffler DA
Am J Gastroenterol; 2015 Feb; 110(2):328-35. PubMed ID: 25512338
[TBL] [Abstract][Full Text] [Related]
7. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation.
Qureshi W; Mittal C; Patsias I; Garikapati K; Kuchipudi A; Cheema G; Elbatta M; Alirhayim Z; Khalid F
Am J Cardiol; 2014 Feb; 113(4):662-8. PubMed ID: 24355310
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal Bleeding on Oral Anticoagulation: What is Currently Known.
Ingason AB; Hreinsson JP; Björnsson ES
Drug Saf; 2022 Dec; 45(12):1449-1456. PubMed ID: 36227528
[TBL] [Abstract][Full Text] [Related]
9. Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation : A Multinational Population-Based Cohort Study.
Lau WCY; Torre CO; Man KKC; Stewart HM; Seager S; Van Zandt M; Reich C; Li J; Brewster J; Lip GYH; Hingorani AD; Wei L; Wong ICK
Ann Intern Med; 2022 Nov; 175(11):1515-1524. PubMed ID: 36315950
[TBL] [Abstract][Full Text] [Related]
10. Management of Oral Anticoagulation Therapy After Gastrointestinal Bleeding: Whether to, When to, and How to Restart an Anticoagulation Therapy.
Kido K; Scalese MJ
Ann Pharmacother; 2017 Nov; 51(11):1000-1007. PubMed ID: 28639882
[TBL] [Abstract][Full Text] [Related]
11. Comparing Major Bleeding Risk in Outpatients With Atrial Fibrillation or Flutter by Oral Anticoagulant Type (from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence Registry).
Wong JM; Maddox TM; Kennedy K; Shaw RE
Am J Cardiol; 2020 May; 125(10):1500-1507. PubMed ID: 32276760
[TBL] [Abstract][Full Text] [Related]
12. Severity of Gastrointestinal Bleeding in Patients Treated with Direct-Acting Oral Anticoagulants.
Brodie MM; Newman JC; Smith T; Rockey DC
Am J Med; 2018 May; 131(5):573.e9-573.e15. PubMed ID: 29175237
[TBL] [Abstract][Full Text] [Related]
13. Resuming Anticoagulation Following Hospitalization for Gastrointestinal Bleeding Is Associated with Reduced Thromboembolic Events and Improved Mortality: Results from a Systematic Review and Meta-Analysis.
Tapaskar N; Pang A; Werner DA; Sengupta N
Dig Dis Sci; 2021 Feb; 66(2):554-566. PubMed ID: 32279174
[TBL] [Abstract][Full Text] [Related]
14. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding.
Witt DM; Delate T; Garcia DA; Clark NP; Hylek EM; Ageno W; Dentali F; Crowther MA
Arch Intern Med; 2012 Oct; 172(19):1484-91. PubMed ID: 22987143
[TBL] [Abstract][Full Text] [Related]
15. Predicting major bleeding among hospitalized patients using oral anticoagulants for atrial fibrillation after discharge.
Qazi JZ; Schnitzer ME; Côté R; Martel MJ; Dorais M; Perreault S
PLoS One; 2021; 16(3):e0246691. PubMed ID: 33657116
[TBL] [Abstract][Full Text] [Related]
16. Proton Pump Inhibitor Co-Therapy in Patients with Atrial Fibrillation Treated with Oral Anticoagulants and a Prior History of Upper Gastrointestinal Tract Bleeding.
Lee SR; Kwon S; Choi EK; Jung JH; Han KD; Oh S; Lip GYH
Cardiovasc Drugs Ther; 2022 Aug; 36(4):679-689. PubMed ID: 33730289
[TBL] [Abstract][Full Text] [Related]
17. Major gastrointestinal bleeding risk with direct oral anticoagulants: Does type and dose matter? - A systematic review and network meta-analysis.
Radadiya D; Devani K; Brahmbhatt B; Reddy C
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e50-e58. PubMed ID: 33470705
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation.
Shah S; Norby FL; Datta YH; Lutsey PL; MacLehose RF; Chen LY; Alonso A
Blood Adv; 2018 Feb; 2(3):200-209. PubMed ID: 29378726
[TBL] [Abstract][Full Text] [Related]
19. A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants.
Halvorsen S; Ghanima W; Fride Tvete I; Hoxmark C; Falck P; Solli O; Jonasson C
Eur Heart J Cardiovasc Pharmacother; 2017 Jan; 3(1):28-36. PubMed ID: 27680880
[TBL] [Abstract][Full Text] [Related]
20. Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation.
Jackevicius CA; Lu L; Ghaznavi Z; Warner AL
Circ Cardiovasc Qual Outcomes; 2021 Feb; 14(2):e007230. PubMed ID: 33541109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
